Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 24,278 shares at $176.03 ($4.3M) on 2018-08-09, disclosed to the SEC on 2018-08-13.
Seasonal sale ($4.3M) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.03 | 3,437 | $605K | 14.1% |
| 2 | $176.03 | 3,437 | $605K | 14.1% |
| 3 | $176.15 | 9,000 | $1.6M | 37.1% |
| 4 | $176.31 | 3,542 | $624K | 14.6% |
| 5 | $176.31 | 3,542 | $624K | 14.6% |
| 6 | $176.61 | 660 |
| $117K |
| 2.7% |
| 7 | $176.61 | 660 | $117K | 2.7% |
| Total | $176.19 avg | 24,278 | $4.3M | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |